Strategic sale of Vyne Medical to MRO concentrates leadership, capital, and product investment in dental RCM
Vyne Sharpens Focus on Dental With Sale of Vyne Medical to MRO
Indianapolis, IN , Sept. 17, 2026 (GLOBE NEWSWIRE) — Vyne announced today the sale of Vyne Medical, its clinical data intake, management, and workflow automation platform servicing hospitals and health systems, to MRO, the leading clinical data management platform in healthcare. Vyne Medical’s solutions help healthcare organizations capture, organize, and integrate patient information and other clinical and administrative communications, including fax, voice, documents, images, and electronic data, into existing clinical and revenue cycle workflows and systems.The transaction sharpens Vyne’s strategic focus and concentrates its leadership, capital, and product investment entirely on Vyne Dental, its end-to-end revenue cycle management (RCM) platform connecting dental practices, dental service organizations (DSOs), and payers.
“Vyne Medical is a strong business with an exceptional team, and MRO is the right home to help it grow further. This is a focus decision. The largest, fastest-growing opportunity in front of us is dental RCM, where we already hold a leading position on both the provider and payer side of the revenue cycle. Concentrating our resources here lets us drive innovation rather than split our attention across two important but different healthcare segments,” said Steve Roberts, CEO of Vyne.
Vyne Dental
Vyne Dental’s platform connectivity is built on relationships across the dental technology ecosystem, and the company will invest in both expanding that network and deepening the partnerships already in place, working closely with practice management, distribution, and payer partners to make data move cleanly between every party in the transaction.
Solution fragmentation costs our customers time, money, and better outcomes. They want one partner that does more, not more partners. This transaction gives us added capacity, from both a capital and resources perspective, to deliver better-connected solutions that optimize provider revenue while reducing the time practices spend managing software and transactions instead of patients,” said Sajid Khan, Chief Business Officer of Vyne.
As a dental-focused revenue cycle management company, Vyne Dental will accelerate its product innovation roadmap, expand enterprise and DSO capabilities, and increase investment in AI across the entire reimbursement lifecycle. Additionally, the business will continue to pursue strategic acquisitions to broaden its platform’s capabilities and expand its payer network services.
“Vyne Dental holds a leading position in dental revenue cycle management, and this transaction lets Steve and the team put all of their energy behind it,” said Dan Williams, Partner and Head of Healthcare at TJC. “We will continue to back the company’s product roadmap and its acquisition strategy as it builds the platform that connects dental practices, DSOs, and payers. We also thank the Vyne Medical team and wish them every success as part of MRO.”
Vyne Medical will operate as “Vyne Medical, an MRO Company” during the transition period, and its clients will continue to be supported by the same team without interruption.
Vyne Dental remains a portfolio company of TJC, L.P. (“TJC”), a middle-market private equity firm formerly known as The Jordan Company. Financial terms of the transaction were not disclosed.
About Vyne Dental
Vyne Dental is a complete revenue cycle management platform for the dental industry, connecting insurance verification, claims and attachments, patient communications, and payments in one system for dental practices and DSOs. Thousands of dental organizations rely on Vyne Dental to reduce administrative burden, get paid faster, and deliver a better patient financial experience. For more information, visit www.vynedental.com.
About TJC
TJC LP, formerly known as The Jordan Company, has worked for more than 40 years with CEOs, founders and entrepreneurs across a range of industries including Diversified Industrials, Industrial Technology, Logistics & Business Services, Digital & Power Infrastructure, Healthcare and Consumer. With $31.3 billion of assets under management as of June 30, 2026, TJC is managed by a senior leadership team that has invested together for over 24 years on over 90 investments. TJC has offices in New York, Chicago, Miami and Stamford. For more information, please visit www.tjclp.com.
Media Contact
Ashton Pena, Director of Marketing
[email protected]
(770) 268-2739
Attachment
- Vyne Sharpens Focus on Dental With Sale of Vyne Medical to MRO
